New Prescription Drug Outperforms Aspirin in Preventing Heart Attacks and Strokes
A study published in The BMJ suggests that P2Y12 inhibitors may be more effective than aspirin in reducing cardiovascular death, heart attack, and stroke in patients with coronary artery disease, without increasing major bleeding risk, over a medium-term follow-up of around four years.